Cellectis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MBIO | D | Mustang Bio, Inc. | -4.61 | |
PSTX | D | Poseida Therapeutics, Inc. | 4.22 | |
CLLS | F | Cellectis S.A. | 1.12 |
Related Industries: Biotechnology
Related Stock Lists:
Biopharmaceutical
Chimeric Antigen Receptor
Medicine
Cancer
Cancer Treatment
Immune System
Leukemia
Solid Tumors
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Adoptive Cell Transfer
Biotechnology
Blastoma
CD19
Cancer Cell
Cancer Immunotherapy
Cancer Immunotherapy Product
Cell Product
Chimeric Antigen Receptor T Cell
Chronic Lymphocytic Leukemia
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
GNOM | F | Global X Genomics & Biotechnology ETF | 0.33 | |
IWC | B | iShares Microcap ETF | 0.04 | |
GSSC | B | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.02 | |
APIE | D | Trust for Professional Managers ActivePassive International Equity ETF | 0.01 | |
ITWO | D | ProShares Russell 2000 High Income ETF | 0.01 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Biopharmaceutical
Chimeric Antigen Receptor
Medicine
Cancer
Cancer Treatment
Immune System
Leukemia
Solid Tumors
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Adoptive Cell Transfer
Biotechnology
Blastoma
CD19
Cancer Cell
Cancer Immunotherapy
Cancer Immunotherapy Product
Cell Product
Chimeric Antigen Receptor T Cell
Chronic Lymphocytic Leukemia
- Cellectis
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris and New York City.
Popular Now
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Featured Articles